These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 31755174)

  • 41. Involvement of miR-140-3p in Wnt3a and TGFβ3 signaling pathways during osteoblast differentiation in MC3T3-E1 cells.
    Fushimi S; Nohno T; Nagatsuka H; Katsuyama H
    Genes Cells; 2018 Jul; 23(7):517-527. PubMed ID: 29740905
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Circulating miR-374b-5p negatively regulates osteoblast differentiation in the progression of osteoporosis via targeting Wnt3 AND Runx2.
    Xu Y; Zhang S; Fu D; Lu D
    J Biol Regul Homeost Agents; 2020; 34(2):345-355. PubMed ID: 32548991
    [TBL] [Abstract][Full Text] [Related]  

  • 43. IGF-1 Receptor Insufficiency Leads to Age-Dependent Attenuation of Osteoblast Differentiation.
    Yeh LC; Wilkerson M; Lee JC; Adamo ML
    Endocrinology; 2015 Aug; 156(8):2872-9. PubMed ID: 26076041
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Circular RNA CDR1as regulates osteoblastic differentiation of periodontal ligament stem cells via the miR-7/GDF5/SMAD and p38 MAPK signaling pathway.
    Li X; Zheng Y; Zheng Y; Huang Y; Zhang Y; Jia L; Li W
    Stem Cell Res Ther; 2018 Aug; 9(1):232. PubMed ID: 30170617
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hypoxia-inducible factor 1Α may regulate the commitment of mesenchymal stromal cells toward angio-osteogenesis by mirna-675-5P.
    Costa V; Raimondi L; Conigliaro A; Salamanna F; Carina V; De Luca A; Bellavia D; Alessandro R; Fini M; Giavaresi G
    Cytotherapy; 2017 Dec; 19(12):1412-1425. PubMed ID: 29111380
    [TBL] [Abstract][Full Text] [Related]  

  • 46. miR-409-5p negatively regulates Wnt/Beta catenin signaling pathway by targeting Lrp-8.
    Prakash R; John AA; Singh D
    J Cell Physiol; 2019 Dec; 234(12):23507-23517. PubMed ID: 31165485
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IGF-I regulates tight-junction protein claudin-1 during differentiation of osteoblast-like MC3T3-E1 cells via a MAP-kinase pathway.
    Hatakeyama N; Kojima T; Iba K; Murata M; Thi MM; Spray DC; Osanai M; Chiba H; Ishiai S; Yamashita T; Sawada N
    Cell Tissue Res; 2008 Nov; 334(2):243-54. PubMed ID: 18855015
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MicroRNA-139-3p regulates osteoblast differentiation and apoptosis by targeting ELK1 and interacting with long noncoding RNA ODSM.
    Wang Y; Wang K; Hu Z; Zhou H; Zhang L; Wang H; Li G; Zhang S; Cao X; Shi F
    Cell Death Dis; 2018 Oct; 9(11):1107. PubMed ID: 30382082
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IL-1α induces apoptosis and inhibits the osteoblast differentiation of MC3T3-E1 cells through the JNK and p38 MAPK pathways.
    Guo C; Yang XG; Wang F; Ma XY
    Int J Mol Med; 2016 Jul; 38(1):319-27. PubMed ID: 27220839
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enrichment of miR-126 enhances the effects of endothelial progenitor cell-derived microvesicles on modulating MC3T3-E1 cell function via Erk1/2-Bcl-2 signalling pathway.
    Chen G; Li P; Liu Z; Zeng R; Ma X; Chen Y; Xu H; Li Z; Lin H
    Prion; 2019 Jan; 13(1):106-115. PubMed ID: 31050590
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of microRNA-129-5p in osteoblast differentiation from bone marrow mesenchymal stem cells.
    Xiao WZ; Gu XC; Hu B; Liu XW; Zi Y; Li M
    Cell Mol Biol (Noisy-le-grand); 2016 Mar; 62(3):95-9. PubMed ID: 27064880
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Over-expression of miR-411-5p and miR-434-3p promotes the osteoblast differentiation by targeting GATA4.
    Gao X; Ge J; Li W; Zhou WC; Xu L; Geng DQ
    Mol Cell Endocrinol; 2020 Apr; 506():110759. PubMed ID: 32061766
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MiR-5100 promotes osteogenic differentiation by targeting Tob2.
    Wang H; Cui Y; Luan J; Zhou X; Li C; Li H; Shi L; Han J
    J Bone Miner Metab; 2017 Nov; 35(6):608-615. PubMed ID: 27873073
    [TBL] [Abstract][Full Text] [Related]  

  • 54. miR-216a rescues dexamethasone suppression of osteogenesis, promotes osteoblast differentiation and enhances bone formation, by regulating c-Cbl-mediated PI3K/AKT pathway.
    Li H; Li T; Fan J; Li T; Fan L; Wang S; Weng X; Han Q; Zhao RC
    Cell Death Differ; 2015 Dec; 22(12):1935-45. PubMed ID: 26206089
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Overexpression of MiR-335-5p Promotes Bone Formation and Regeneration in Mice.
    Zhang L; Tang Y; Zhu X; Tu T; Sui L; Han Q; Yu L; Meng S; Zheng L; Valverde P; Tang J; Murray D; Zhou X; Drissi H; Dard MM; Tu Q; Chen J
    J Bone Miner Res; 2017 Dec; 32(12):2466-2475. PubMed ID: 28846804
    [TBL] [Abstract][Full Text] [Related]  

  • 56. miR-182 is a negative regulator of osteoblast proliferation, differentiation, and skeletogenesis through targeting FoxO1.
    Kim KM; Park SJ; Jung SH; Kim EJ; Jogeswar G; Ajita J; Rhee Y; Kim CH; Lim SK
    J Bone Miner Res; 2012 Aug; 27(8):1669-79. PubMed ID: 22431396
    [TBL] [Abstract][Full Text] [Related]  

  • 57. miR-124 negatively regulates osteogenic differentiation and in vivo bone formation of mesenchymal stem cells.
    Qadir AS; Um S; Lee H; Baek K; Seo BM; Lee G; Kim GS; Woo KM; Ryoo HM; Baek JH
    J Cell Biochem; 2015 May; 116(5):730-42. PubMed ID: 25424317
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Osteoblast-specific overexpression of complement receptor C5aR1 impairs fracture healing.
    Bergdolt S; Kovtun A; Hägele Y; Liedert A; Schinke T; Amling M; Huber-Lang M; Ignatius A
    PLoS One; 2017; 12(6):e0179512. PubMed ID: 28614388
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MicroRNA-92a-1-5p influences osteogenic differentiation of MC3T3-E1 cells by regulating β-catenin.
    Lin Z; Tang Y; Tan H; Cai D
    J Bone Miner Metab; 2019 Mar; 37(2):264-272. PubMed ID: 30019248
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sclerostin antibody treatment improves fracture outcomes in a Type I diabetic mouse model.
    Yee CS; Xie L; Hatsell S; Hum N; Murugesh D; Economides AN; Loots GG; Collette NM
    Bone; 2016 Jan; 82():122-34. PubMed ID: 25952969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.